SFRP1 and non-small cell lung carcinoma: In this study, DNMT3A had been identified as the target of miR-26a-5p and acted as an oncogene role in NSCLC through repressing SFRP1 via DNA methylation modification to suppress Wnt/β-catenin pathway.